CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $908 | -19.1% | 20 | 0.0% | 0.00% | – |
| Q2 2023 | $1,123 | +24.1% | 20 | 0.0% | 0.00% | – |
| Q1 2023 | $905 | +11.3% | 20 | 0.0% | 0.00% | – |
| Q4 2022 | $813 | -18.7% | 20 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -95.5% | 20 | -93.1% | 0.00% | -100.0% |
| Q4 2021 | $22,000 | -31.2% | 289 | 0.0% | 0.01% | -36.4% |
| Q3 2021 | $32,000 | -31.9% | 289 | 0.0% | 0.01% | -31.2% |
| Q2 2021 | $47,000 | +34.3% | 289 | 0.0% | 0.02% | +14.3% |
| Q1 2021 | $35,000 | -20.5% | 289 | 0.0% | 0.01% | -26.3% |
| Q4 2020 | $44,000 | +100.0% | 289 | +7.4% | 0.02% | +72.7% |
| Q3 2020 | $22,000 | – | 269 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |